Global Barriers to the Diagnosis of Multiple Sclerosis
Andrew Solomon(University of Vermont), Anne Helme(Multiple Sclerosis International Federation), Rachel King(Multiple Sclerosis International Federation), Russell T. Shinohara, Lindsay Rechtman(Children's Hospital Research Institute of Manitoba), Jorge Correale(Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia), Deanna Saylor(Johns Hopkins University), Joanna Laurson-Doube(Multiple Sclerosis International Federation), Wendy Kaye(Children's Hospital Research Institute of Manitoba), Eunchan Bae(Children's Hospital Research Institute of Manitoba), Ruth Ann Marrie(Manitoba Health), Melinda Magyari(University of Copenhagen), Neil P. Robertson(Cardiff University), Shanthi Viswanathan(Children's Hospital Research Institute of Manitoba)
Cited by 80
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k
Ofatumumab versus Teriflunomide in Multiple Sclerosis
|New England Journal of Medicine|2020|706
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624